Brimonidine-d4 D-Tartrate (5-Bromo-N-(4,5-dihydro-1H-imidazol-d4-2-yl)-6-quinoxalinamine D-Tartrate, 5-Bromo-6-(2-imidazolin-d4-2-ylamino)quinoxaline, UK-14304-18-d4, AGN-190342-LF-d4, Alphagan-d4), CAS [[1316758-27-6 unlabelled:

Produktübersicht

• Artikelname: Brimonidine-d4 D-Tartrate (5-Bromo-N-(4,5-dihydro-1H-imidazol-d4-2-yl)-6-quinoxalinamine D-Tartrate, 5-Bromo-6-(2-imidazolin-d4-2-ylamino)quinoxaline, UK-14304-18-d4, AGN-190342-LF-d4, Alphagan-d4), CAS [[1316758-27-6 unlabelled:
• Artikelnummer: USB-B2755-01
• Hersteller Artikelnummer: B2755-01
• Alternativnummer: USB-B2755-01-1
• Hersteller: US Biological
• Kategorie: Biochemikalien

Produktbeschreibung

Brimonidine D-Tartrate is an alpha2 receptor agonist. It is a drug used to treat glaucoma and acts via decreasing aqueous humor synthesis. Melting Point: 205-207.5C (decomposes) Solubility: DMSO, Methanol (sparingly) Atmosphere: Air Method for Determining Identity: Proton NMR Spectroscopic Analysis and Mass Spectrometric Analysis TLC Conditions: SiO2, Dichloromethane: Methanol: NH4OH (90:10:1). Visualized with UV and KMnO4. Single spot, Rf=0.3 Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Produkteigenschaften

• Molekulargewicht: 446.26
• Reinheit: Chemical Purity: 98%, Isotopic Purity: 99%
• Formulierung: Off-white to pale yellow solid
• CAS Nummer: [1316758-27-6 unlabelled: 1350706-20-5]